Gloria C Li

Title: Gloria C. Li: Innovator in Cancer Research

Introduction

Gloria C. Li is a prominent inventor based in New York, NY, known for her significant contributions to cancer research. She holds a total of 4 patents that focus on enhancing the susceptibility of cells to DNA-damaging agents, which is crucial for developing effective cancer treatments.

Latest Patents

Her latest patents include innovative methods that utilize DNA-PK to increase the sensitivity of cells and tumors to various DNA-damaging agents. One of her inventions provides methods for treating tumors by introducing antisense oligonucleotides that prevent the expression of DNA-dependent protein kinase catalytic subunits, specifically Ku70 or Ku80. This approach aims to enhance the effectiveness of heat, chemical, or radiation-induced DNA damage in cancer cells. Another patent outlines a similar method for increasing the susceptibility of cells to DNA-damaging agents, emphasizing the importance of antisense oligonucleotides in cancer therapy.

Career Highlights

Gloria C. Li is affiliated with the Sloan Kettering Institute for Cancer Research, where she continues to advance her research in the field of oncology. Her work is pivotal in developing new strategies for cancer treatment, focusing on the molecular mechanisms that govern cell sensitivity to DNA damage.

Collaborations

Throughout her career, Gloria has collaborated with esteemed colleagues such as Paul W. J. J. Burgman and Carlos Cordon-Cardo. These collaborations have further enriched her research and contributed to the advancement of cancer therapies.

Conclusion

Gloria C. Li's innovative work in cancer research exemplifies the critical role of inventors in developing new medical treatments. Her patents and ongoing research efforts are paving the way for more effective cancer therapies, ultimately benefiting patients worldwide.